Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 11 studies | 25% ± 9% | |
vein endothelial cell | 6 studies | 30% ± 18% | |
epithelial cell | 5 studies | 33% ± 21% | |
type II pneumocyte | 4 studies | 18% ± 2% | |
microglial cell | 4 studies | 21% ± 4% | |
dendritic cell | 4 studies | 26% ± 7% | |
monocyte | 4 studies | 19% ± 4% | |
endothelial cell of vascular tree | 4 studies | 24% ± 12% | |
classical monocyte | 3 studies | 21% ± 3% | |
conventional dendritic cell | 3 studies | 18% ± 3% | |
abnormal cell | 3 studies | 26% ± 11% | |
club cell | 3 studies | 17% ± 1% | |
macrophage | 3 studies | 22% ± 4% |
Insufficient scRNA-seq data for expression of TNFRSF10B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 5043.55 | 89 / 89 | 100% | 69.51 | 898 / 901 |
stomach | 100% | 3213.81 | 359 / 359 | 100% | 51.25 | 285 / 286 |
intestine | 100% | 4235.28 | 966 / 966 | 100% | 57.64 | 525 / 527 |
esophagus | 100% | 2841.85 | 1441 / 1445 | 99% | 53.76 | 182 / 183 |
lung | 100% | 6771.23 | 577 / 578 | 99% | 54.64 | 1143 / 1155 |
bladder | 100% | 3424.86 | 21 / 21 | 98% | 48.14 | 496 / 504 |
thymus | 100% | 5182.90 | 652 / 653 | 99% | 48.99 | 596 / 605 |
uterus | 100% | 3580.12 | 170 / 170 | 98% | 51.14 | 448 / 459 |
pancreas | 100% | 3930.69 | 328 / 328 | 97% | 62.31 | 173 / 178 |
breast | 100% | 5105.62 | 459 / 459 | 95% | 28.89 | 1060 / 1118 |
prostate | 100% | 4509.67 | 245 / 245 | 95% | 21.41 | 475 / 502 |
liver | 100% | 5854.62 | 226 / 226 | 93% | 31.49 | 377 / 406 |
ovary | 100% | 4843.48 | 180 / 180 | 90% | 20.08 | 388 / 430 |
skin | 98% | 5119.24 | 1767 / 1809 | 91% | 60.11 | 431 / 472 |
adrenal gland | 100% | 6792.00 | 258 / 258 | 56% | 18.16 | 128 / 230 |
brain | 44% | 592.29 | 1153 / 2642 | 85% | 23.69 | 601 / 705 |
adipose | 100% | 5909.45 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 6013.73 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 17.36 | 1 / 1 |
heart | 99% | 2970.34 | 854 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 3500.18 | 1312 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 67.33 | 44 / 45 |
lymph node | 0% | 0 | 0 / 0 | 97% | 35.34 | 28 / 29 |
peripheral blood | 90% | 4445.34 | 837 / 929 | 0% | 0 | 0 / 0 |
muscle | 87% | 1644.61 | 699 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 81% | 19.67 | 65 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002357 | Biological process | defense response to tumor cell |
GO_0006915 | Biological process | apoptotic process |
GO_0007250 | Biological process | activation of NF-kappaB-inducing kinase activity |
GO_0070059 | Biological process | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress |
GO_0008625 | Biological process | extrinsic apoptotic signaling pathway via death domain receptors |
GO_0036462 | Biological process | TRAIL-activated apoptotic signaling pathway |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0071260 | Biological process | cellular response to mechanical stimulus |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0034976 | Biological process | response to endoplasmic reticulum stress |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0009986 | Cellular component | cell surface |
GO_0005886 | Cellular component | plasma membrane |
GO_0036463 | Molecular function | TRAIL receptor activity |
GO_0038023 | Molecular function | signaling receptor activity |
GO_0045569 | Molecular function | TRAIL binding |
GO_0005515 | Molecular function | protein binding |
Gene name | TNFRSF10B |
Protein name | Tumor necrosis factor receptor superfamily member 10B (Death receptor 5) (TNF-related apoptosis-inducing ligand receptor 2) (TRAIL receptor 2) (TRAIL-R2) (CD antigen CD262) TNFRSF10B protein (Tumor necrosis factor receptor superfamily, member 10b) (cDNA FLJ76289, highly similar to Homo sapiens tumor necrosis factor receptor superfamily, member 10b (TNFRSF10B), transcript variant 1, mRNA) TNF receptor superfamily member 10b Tumor necrosis factor receptor superfamily, member 10b Tumor necrosis factor receptor superfamily member 10B |
Synonyms | ZTNFR9 hCG_1645072 TRICK2 UNQ160/PRO186 KILLER DR5 TRAILR2 |
Description | FUNCTION: Receptor for the cytotoxic ligand TNFSF10/TRAIL . The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. Promotes the activation of NF-kappa-B. Essential for ER stress-induced apoptosis. . FUNCTION: Receptor for the cytotoxic ligand TNFSF10/TRAIL. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. . FUNCTION: Receptor for the cytotoxic ligand TNFSF10/TRAIL. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. . FUNCTION: Receptor for the cytotoxic ligand TNFSF10/TRAIL. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. . |
Accessions | E9PBT3 O14763 ENST00000276431.9 [O14763-1] ENST00000523504.5 Q6FH58 D3DSR9 ENST00000347739.3 [O14763-2] B5BU36 |